- Home
- CRMD vs SABR Comparison
CRMD vs SABR Comparison
Compare CRMD & SABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- SABR
- Stock Information
- Founded
- CRMD 2006
- SABR 2006
- Country
- CRMD United States
- SABR United States
- Employees
- CRMD N/A
- SABR N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- SABR Computer Software: Programming Data Processing
- Sector
- CRMD Health Care
- SABR Technology
- Exchange
- CRMD Nasdaq
- SABR Nasdaq
- Market Cap
- CRMD 849.8M
- SABR 981.2M
- IPO Year
- CRMD 2010
- SABR 2014
- Fundamental
- Price
- CRMD $13.18
- SABR $2.70
- Analyst Decision
- CRMD Strong Buy
- SABR Hold
- Analyst Count
- CRMD 6
- SABR 4
- Target Price
- CRMD $15.00
- SABR $4.15
- AVG Volume (30 Days)
- CRMD 1.7M
- SABR 5.8M
- Earning Date
- CRMD 05-06-2025
- SABR 07-31-2025
- Dividend Yield
- CRMD N/A
- SABR N/A
- EPS Growth
- CRMD N/A
- SABR N/A
- EPS
- CRMD 0.28
- SABR N/A
- Revenue
- CRMD $82,553,827.00
- SABR $3,023,296,000.00
- Revenue This Year
- CRMD $238.38
- SABR $2.85
- Revenue Next Year
- CRMD $53.52
- SABR $3.47
- P/E Ratio
- CRMD $47.48
- SABR N/A
- Revenue Growth
- CRMD N/A
- SABR 2.56
- 52 Week Low
- CRMD $3.61
- SABR $1.93
- 52 Week High
- CRMD $13.85
- SABR $4.63
- Technical
- Relative Strength Index (RSI)
- CRMD 69.49
- SABR 53.82
- Support Level
- CRMD $11.88
- SABR $2.50
- Resistance Level
- CRMD $12.90
- SABR $2.69
- Average True Range (ATR)
- CRMD 0.55
- SABR 0.12
- MACD
- CRMD -0.07
- SABR -0.00
- Stochastic Oscillator
- CRMD 90.00
- SABR 48.15
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The travel solutions segment represented 91% of total 2024 revenue, split between distribution (79% of segment sales) and airline IT solutions (21%) revenue. The company also has a growing hotel IT solutions division (9% of revenue). Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.